Tag Archives: Impax

CI & Patent News:26/11/2010

Pronova BioPharma receives Lovaza(TM) Paragraph IV Notice Letter from Apotex Inc (Press release) Impax Laboratories Confirms Patent Challenge Relating to SIMCOR® Extended-Release Tablets, 1000/20 mg (link) Paragraph IV litigation: 1) Merck & Co., Inc Vs Hetero Drugs & Invagen Pharmaceuticals (No … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , , , | Leave a comment

CI & Patent News: 22/11/2010

1) Paragraph IV Litigation: Impax Confirms Patent Challenge Relating to WELCHOL® (Colesevelam HCl) for Oral Suspension, 3.75 gm/packet and 1.875 gm/packet (Link). Colesevelam is bile acid sequestrant.  Genzyme is originator for Colesevelam and is marketed by Daiichi sankyo in USA. Colesevelam is co … Continue reading

Posted in Daily interesting IP news | Tagged , , , | Leave a comment